Purpose. The quality and economic implications of manual versus automated preparation of antineoplastic drugs were compared. Methods. This four-week study evaluated 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) prepared by manual and automated procedures. The accuracy of the dose of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. A comparative economic analysis of the manual and automated preparation procedures was performed by calculating the mean unit cost for each preparation at different production levels. Participating pharmacists and technicians completed a survey rating each preparation method in terms of performance, operator satisfaction, technology, and safety.
T
he manual preparation of cytotoxic drugs has always been considered a high-risk activity given the prolonged exposure to carcinogens during handling [1] [2] [3] [4] [5] and the extreme personalization of therapies, which multiplies the possibility of error. [6] [7] [8] [9] [10] [11] [12] [13] In addition, the drugs involved are often highly toxic with a low therapeutic index, highlighting the need for great precision throughout the entire therapeutic process in order to safeguard the patient. 14 Computerization of the therapeutic process and the introduction of robots have improved the safety of cytotoxic drug preparation, reducing the number of errors during a highrisk part of the process to almost zero. [15] [16] [17] [18] Computerized order entry has removed the possibility of transcription errors, and the introduction of automation has eliminated the risk of errors associated with the identification of products, solvents, and diluents during the final phase of preparation.
In addition to decreasing the number of errors and risk to personnel from exposure to carcinogenic substances, the use of robots aims to improve product quality in terms of both the accuracy of the drug dosage and the sterility of the finished product. However, current knowledge of the improvements resulting from the implementation of automated Am J Health-Syst Pharm-Vol 71 Apr 1, 2014 preparation systems is still limited. Although automated systems are already in use in some national centers (e.g., European Institute of Oncology in Milan, University Hospital of Ancona) and international centers (e.g., Cleveland Clinic 19 and Wake Forest Baptist Medical Center in the United States, Mie University Hospital in Japan, University Hospital of Mainz in Germany, Capital Region Pharmacy Rigshospitalet in Denmark, Hospital Clínico San Carlos in Spain, Celal Bayar University in Turkey), very few studies have compared the quality and cost implications associated with manual versus robot-assisted drug preparation.
We conducted a four-week trial to prospectively compare manual and automated procedures in terms of quality and economic sustainability. Ten drugs routinely used for cancer therapies were chosen on the basis of chemical-physical stability (at least 24 hours after dilution), high volume of preparations made, dosage form (e.g., injection, infusion bag), and available formulation (powder or liquid).
Background
At our cancer institute in ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST IRCCS)-which comprises 36 inpatient beds and 30 outpatient beds in three day hospitals located within 30 km of each other, a highly equipped and specialized central pharmacy is in charge of cancer therapies. In 2011, 44,576 antineoplastic therapies were prepared, 39,026 of which were parenteral preparations for 2,600 patients.
Drugs are prepared by technicians working under vertical laminar-airflow hoods situated in specific areas of the oncology pharmacy. All activities are regulated by internal working procedures developed in compliance with current Italian pharmacopeia guidelines, 20 a standard quality management system (UNI EN ISO-9001:2008), and national guidelines for the health of workers exposed to antineoplastic drugs in the workplace.
1,2 The entire medication-use process is computerized, using an internally developed software program (Log80), guaranteeing the traceability and control of all phases of the process from prescription to administration and thus substantially reducing the margin of error. In 2011, the IRST pharmacy was equipped with a new automated system (APOTECAchemo, Loccioni Human Care, Ancona, Italy) for the preparation of antineoplastic therapies.
Methods
This study, performed over four weeks, evaluated the quality and cost implications of preparing 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) by manual and automated procedures. During the first week of the study, three drugs (fluorouracil, etoposide, and trastuzumab) were prepared manually, while the remaining 7 were prepared with the automated procedure. This division was necessary to balance the number of preparations for each study group. The scheme was inverted during the second week and then alternated for the remaining two weeks of the study. Only two technicians were involved in this study to reduce technician-related bias. The study design is shown in Figure 1 . Manual drug preparation. Due to the large number of drugs prepared at IRST on a daily basis, the manual process has a product-line structure in which active ingredients are processed individually and added to other ancillary drugs at the end of the entire production cycle. The presence of two technicians is required for the manual procedure; the first operator prepares the drugs in a vertical laminarairflow-hood, while the second operator ensures that the first operator has all the material necessary for the preparation (drug, diluents, and disposables), in accordance with Italian pharmacopeia guidelines. 20 All data regarding the preparation process are recorded on a worksheet to ensure the correctness of the preparation. At the end of each production cycle, the pharmacist and laboratory technician check that the quantity of drug residue corresponds to the amount calculated by the computer program. Data about the dosage of active ingredients are obtained gravimetrically using Sartorius CP precision scales (Sartorius AG, Goettingen, Germany) under the laminar hood. 21 The scales are connected via a USB cable to a laptop running Log80 software. The preparation time is calculated as the difference between the first and last times that components are weighed. Data on drug density or the conversion of weight to volume are provided by pharmaceutical companies.
Robotic drug preparation. The APOTECAchemo automated system was installed in the pharmacy laboratory in 2011. The central part of the system, located within a closed and microbiologically controlled environment, comprises a robot with an anthropomorphic arm that mechanically replicates the manual actions of a human operator. The system permits us to continuously verify and check the entire preparation process. All of the production steps, as well as incoming and outgoing materials, are checked and registered by technological controls such as sensors, photocells, a vision system, and barcode readers. The automatic identification of drugs, weight-checking system, and barcode labeling are used to guarantee complete traceability of the process.
High-performance liquid chromatography method. We performed a qualitative-quantitative analysis of two drugs (cisplatin and oxaliplatin) in this study to compare the nominal concentration specified in the medical prescription with the real concentration of the preparation.
The measurements were made using a high-performance liquid chromatography (HPLC) system (1200 Series, Agilent Technologies Italia S.p.a., Cernusco, Italy). 22, 23 The accuracy of the concentration of active ingredients could not be calculated because bags are generally overfilled by technicians (often 40-50% more than the declared nominal volume), making it impossible to determine the drug's final concentration. Sterility checks were performed on 37 randomly selected manual (n = 17) and automated (n = 20) preparation samples used for the HPLC analysis. Two types of culture media-one for aerobic bacteria and the other for anaerobic bacteria (BacT/ALERT, BioMerieux Italia S.p.a., Bagno a Ripoli, Italy)-were used to evaluate the presence of bacteria in each sample.
Cost analysis. A comparative economic analysis of the manual and automated preparation procedures was performed by calculating the mean unit cost for each preparation at different production levels. Costs calculated included the variable unit cost of disposable materials and technician and pharmacist direct labor costs at current national standard hourly rates (€12/hr for technicians and €39.9/hr for pharmacists), as well as fixed costs directly attributable to production (e.g., instrumentation).
Questionnaire. A multiple-choice questionnaire consisting of 13 questions was developed for technicians and pharmacists to complete at the end of the study, asking them to compare the manual and automated preparation procedures with respect to four specific areas: performance, operator satisfaction, technology, and safety. A 5-point Likert scale was used to rate these items.
Statistical analysis. The accuracy of the dose of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. Although the Italian pharmacopeia 20 allows a variance of 10%, we set an acceptable variance limit of 5%. All analyses performed were descriptive. Means, standard deviations, and percentages were calculated.
Results
Product quality. Of the 2500 i.v. antineoplastic preparations made in our pharmacy during the four-week study period, 681 were analyzed (348 using the automated procedure and 333 manually) ( Table 1) . Both procedures were shown to be accurate and precise. For the manual preparation procedure, the minimum percent relative error was observed with beva cizumab preparations (-0.28%), while the maximum percent relative error was observed with oxaliplatin preparations (-1.6%) ( Table 1) . Precision varied from 0.62 for bevacizumab and cyclophosphamide to 2.05 for fluorouracil bolus preparations. In the automated procedure the highest accuracy was found for fluorouracil bag preparations (-0.19%) and the lowest for trastuzumab preparations (-3.71%). Similarly, precision varied from 0.57 for cisplatin to 1.92 for gemcitabine. With the exception of cisplatin preparations (0.42%) in the automated procedure and fluorouracil bolus preparations (0.91%) in the manual procedure, the deviation for drug concentration compared with the prescribed concentration always showed negative values ( Table 1) .
Accuracy of the concentration of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. We allowed a variance of no more than 5%. Of the 681 preparations analyzed, 17 (2.49%) had a percent relative error that varied by over 5%; 1 (0.15%) varied by more than 10%. With regard to the automated procedure, Am J Health-Syst Pharm-Vol 71 Apr 1, 2014 13 (3.73%) preparations had a percent relative error exceeding 5%: 3 gemcitabine preparations (-5.15%, -6.88%, and -9.21%) and 10 trastuzumab (-5.18%, -5.27%, -5.32%, -5.69%, -6.15%, -6.38%, -6.39%, -7.48%, -7.49%, and -8.06%). Results for trastuzumab can be attributed to a systematic nonrandom error, which was subsequently corrected by recalibrating a number of variables relating to the trastuzumab-containing vials; the new mean ± S.D. percent relative error obtained (-0.91% ± a A systematic error was detected; once new variables were established to correct the error, the mean ± S.D. % relative error was 0.91% ± 1.31%. . Fixed costs were higher with the automated procedure, the contract for the use of the equipment amounting to €66,000 annually versus €6,110 for machinery amortization in the manual procedure.
A comparative cost-volume analysis of the two systems was performed, and the breakeven point between the two methods was identified at a volume of 34,000 preparations annually (Figure 2) . Beyond this production level, the automated preparation method would become increasingly advantageous.
Working conditions. The laboratory staff gave a positive evaluation of the automated preparation system (question 13 in the questionnaire), and the automated procedure was preferred to the manual one in all aspects apart from that of the preparation time (questions 1 and 2) (Table 3) . Overall, the automated preparation procedure was preferred because of the possibility of obtaining information on errors (questions 3 and 4), the perception of improved technician and patient safety (questions 9-12), and better software support (questions 7 and 8).
Mean ± S.D. Preparation Times for Automated and Manual Procedures

Discussion
This study compared manual and automated preparation processes in terms of accuracy during drug preparation, costs, and working conditions. Both procedures proved to be accurate and precise. The automated procedure resulted in substantial advantages in terms of quality and risk lowering.
Questionnaire results revealed that employees perceived preparation times as faster with the manual procedure, which was, in fact, confirmed in our analysis. The questionnaire also highlighted that the manual procedure is more taxing because the critical steps involved require the constant attention and concentration of the technicians. In the automated procedure, technicians were conscious of better safety conditions and thus worked in a more relaxed manner. The instrumentation was welcomed by staff who recognized and appreciated its potential advantages in terms of patient and operator safety, process traceability, error reporting, and software support. The automated procedure was inferior to the manual one only with regard to preparation time. Finally, the questionnaire revealed that operating an innovative automated system for the preparation of chemotherapies motivates staff and improves working techniques and team spirit. With regard to workflow, it was found that the average time spent per preparation was 14.2% higher when using the automated method compared with manual preparation. However, preparation times cannot be fairly compared, because the automated system performs and registers numerous quality checks that are not carried out by technicians during the manual process.
Seger and colleagues 24 of Brigham and Women's Hospital in Boston compared the effects of manual antineoplastic and adjuvant drug preparation with automated preparation (CytoCare, Health Robotics, Bolzano, Italy). The authors analyzed medication errors and staff safety events, medication accuracy, drug preparation time, the cost of materials used during drug preparation, and personnel time. Their study, like ours, focused on accuracy during drug preparation, working conditions, and costs. Although our study was intentionally kept short (four weeks), the number of preparations analyzed Am J Health-Syst Pharm-Vol 71 Apr 1, 2014 was about 50% higher than that of Seger et al.'s 24 and no major errors occurred requiring drug repreparation. In our study, both the automated and manual procedures proved to be precise and accurate, fully complying with current Italian pharmacopeia guidelines. As precision scales are not normally used in laboratory activities, it must be emphasized that the trial period probably resulted in more careful monitoring during the preparation procedures. However, occasional errors in manual dosing, such as the one registered for trastuzumab (-17%), are possible and difficult to intercept, as quality control of the production process does not reach 100%. At the same time, the availability of a gravimetric system in the automated procedure enabled staff to intercept and rectify errors (even very small ones). Both studies set the limit of variance from the concentration prescribed to 5%, even though the Italian pharmacopeia and United States Pharmacopeia allow a 10% limit. 20, 25 Only cisplatin, etoposide, and cyclophosphamide were common to both studies, and the mean percent relative error for these drugs was lower in our study than that of Seger et al. (cisplatin, 1.8% (manual) versus 2.2% (automated); etoposide, 2.7% (manual) versus 3.8% (automated); cyclophosphamide, 1.7% (manual; automated preparation data not available). Comparing our data with those from the American study, 24 operator preparation times for the manual procedure were comparable, probably the result of similar working procedures. Conversely, automated preparation times differed considerably, possibly due to the use of different automated technologies. No machine stoppages requiring maintenance operations were reported in our study. Conversely, failure events specifically attributable to the new technology were reported by Seger and colleagues.
Questionnaire Results Regarding Pharmacists' and Technicians' Perceptions of Automated Versus Manual Preparation Procedures
In our study, the average unit cost for each preparation was lower in the automated procedure than in the manual procedure in terms of labor and disposables. Higher labor costs were incurred because two technicians were needed for the manual procedure compared with only one for the automated preparation. Moreover, the physical presence of the pharmacist was not required as much in the automated procedure. With regard to disposables, the slightly lower cost registered for the APOTECAchemo system was a consequence of the elimination of closed compounding systems used in the manual procedure. Conversely, the automated system incurred higher costs in its use of ventilated noncoring needles for the preparation of compounds and barcode labels during the preparation process.
The results of a breakeven-point analysis revealed a potential cost advantage from the implementation of the automated system after 34,000 drugs have been prepared in a year. This volume of activity is compatible with the production capacity of the institute's pharmacy, though the full production capacity of the automated system has not been reached. In addition, the economic analysis performed during the trial did not account for the costs of poor-quality products, which are economically crucial but dificult to quantify in an Italian context (e.g., costs associated with adverse events and damage or compensation are more likely for the manual method). However, our investigation could be the starting point for analyses of costs incurred by adverse events (insurance and compensation). Therefore, the range of economic acceptability can be extended well beyond the minimum annual volume of production.
Our study was not without limitations. Gravimetric analysis is not routinely used in everyday clinical practice. Furthermore, the technicians were aware that they were part of the study, so it is possible that they were more attentive than they normally would have been during the manual preparation of drugs. Because the study was performed during normal clinical activities, the preparations differed in terms of number and dosage. In addition, the trial was started immediately after a two-week operator training period and shortly after the installation of the automated system, allowing little time for the staff to familiarize themselves with the new technology.
In the present study, one of the first to carry out multidimensional evaluation of new high-tech equipment for the preparation of antineoplastic therapies, the robotic procedure resulted in substantial advantages in terms of quality maintenance standards and lowering of risk. Given the volume of annual production needed to reach the breakeven point, the value of APOTECA chemo technology could be maximized if it were used in a high-volume center.
Conclusion
Both the automated and manual procedures for preparing antineoplastic preparations proved to be accurate and precise. The automated procedure resulted in substantial advantages in terms of quality and risk lowering.
